The once-a-day treatment, which acts on brain chemicals that affect mood and appetite, had initially been OK’d for ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...

The US Food and Drug Administration (FDA) has approved the medication Addyi (flibanserin) as a “female Viagra” for use to treat low sex drive in women after menopause under the age of 65.Addyi, a pill ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

The announcement Monday from the Food and Drug Administration broadens the drug's use to older women who have gone through ...

The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

A first-of-its-kind topical cream designed for women to boost sexual arousal is beginning to roll out in select states.

For more than three decades, men have been able to boost their sexual performance using a little blue pill called Viagra, ...